- Home
- EAD vs BLDEW Comparison
EAD vs BLDEW Comparison
Compare EAD & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAD
- BLDEW
- Stock Information
- Founded
- EAD 2003
- BLDEW 2014
- Country
- EAD United States
- BLDEW United States
- Employees
- EAD N/A
- BLDEW N/A
- Industry
- EAD Finance/Investors Services
- BLDEW Transportation Services
- Sector
- EAD Finance
- BLDEW Consumer Discretionary
- Exchange
- EAD Nasdaq
- BLDEW Nasdaq
- Market Cap
- EAD N/A
- BLDEW N/A
- IPO Year
- EAD N/A
- BLDEW N/A
- Fundamental
- Price
- EAD $7.01
- BLDEW $0.31
- Analyst Decision
- EAD
- BLDEW
- Analyst Count
- EAD 0
- BLDEW 0
- Target Price
- EAD N/A
- BLDEW N/A
- AVG Volume (30 Days)
- EAD 178.9K
- BLDEW 53.7K
- Earning Date
- EAD 01-01-0001
- BLDEW 03-13-2025
- Dividend Yield
- EAD 8.91%
- BLDEW N/A
- EPS Growth
- EAD N/A
- BLDEW N/A
- EPS
- EAD N/A
- BLDEW N/A
- Revenue
- EAD N/A
- BLDEW $241,814,000.00
- Revenue This Year
- EAD N/A
- BLDEW N/A
- Revenue Next Year
- EAD N/A
- BLDEW N/A
- P/E Ratio
- EAD N/A
- BLDEW N/A
- Revenue Growth
- EAD N/A
- BLDEW 12.04
- 52 Week Low
- EAD $5.69
- BLDEW $0.29
- 52 Week High
- EAD $6.81
- BLDEW $0.31
- Technical
- Relative Strength Index (RSI)
- EAD 49.81
- BLDEW N/A
- Support Level
- EAD $7.01
- BLDEW N/A
- Resistance Level
- EAD $7.07
- BLDEW N/A
- Average True Range (ATR)
- EAD 0.04
- BLDEW 0.00
- MACD
- EAD -0.01
- BLDEW 0.00
- Stochastic Oscillator
- EAD 23.08
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.